Company Rani Therapeutics Holdings, Inc.
Equities
RANI
US7530181004
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.32 USD | -1.59% | -7.69% | +30.12% |
Business Summary
Number of employees: 140
Managers
Managers | Title | Age | Since |
---|---|---|---|
Talat Imran
CEO | Chief Executive Officer | 43 | 21-05-31 |
Mir Imran
FOU | Founder | 67 | 21-04-05 |
Svai Sanford
DFI | Director of Finance/CFO | 54 | 21-04-05 |
Jacques Van Dam
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Mir Hashim
CTO | Chief Tech/Sci/R&D Officer | 65 | 21-04-05 |
Bella Vazquez
HRO | Human Resources Officer | - | 21-06-30 |
Eric Groen
LAW | General Counsel | 53 | 21-09-08 |
Kate McKinley
PRN | Corporate Officer/Principal | 47 | 23-05-23 |
Arvinder Dhalla
PRN | Corporate Officer/Principal | - | 21-06-30 |
General Counsel | - | 21-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Laureen DeBuono
BRD | Director/Board Member | 66 | 21-04-05 |
Jean-Luc Butel
BRD | Director/Board Member | 67 | 21-04-05 |
Dennis Ausiello
BRD | Director/Board Member | 78 | 21-04-05 |
Mir Imran
FOU | Founder | 67 | 21-04-05 |
Director/Board Member | 55 | 21-04-05 | |
Talat Imran
CEO | Chief Executive Officer | 43 | 21-05-31 |
Maulik Nanavaty
BRD | Director/Board Member | 62 | 21-04-05 |
Mir Hashim
CTO | Chief Tech/Sci/R&D Officer | 65 | 21-04-05 |
Lisa Rometty
BRD | Director/Board Member | 56 | 22-01-02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 10 | 24,116,000 | 0 | 0 | 26.67 % |
Stock B | 1 | 26,303,871 | 13,446,618 ( 51.12 %) | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.12% | 115M | |
+18.39% | 125B | |
+13.66% | 108B | |
-7.39% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.94% | 16.37B | |
+1.62% | 13.58B | |
+27.86% | 11.66B |
- Stock Market
- Equities
- RANI Stock
- Company Rani Therapeutics Holdings, Inc.